Literature DB >> 1150364

The interaction between alpha-methyl-dopa and tricyclic antidepressants.

H W van Spanning, P A van Zwieten.   

Abstract

The central hypotensive action of alpha-methyl-DOPA is antagonized by tricyclic antidepressants like desipramine and imipramine. This antagonism has been demostrated in chloralose-anaesthetized cats. The drugs to be tested were infused into the left vertebral artery. The antagonism pProbably takes place in the pons-medulla region of the CNS. Probably, the alpha-adrenolytic properties of the tricyclic antidepressants bring about the blockade of central alpha-adrenergic receptors that are stimulated by alpha-methyl-noradrenaline, the biotransformation product of alpha-methyl-DOPA.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1150364

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Biopharm        ISSN: 0340-0026


  6 in total

Review 1.  Pharmacology of centrally acting hypotensive drugs.

Authors:  P A van Zwieten
Journal:  Br J Clin Pharmacol       Date:  1980       Impact factor: 4.335

Review 2.  Clinically significant drug interactions with antidepressants in the elderly.

Authors:  Edoardo Spina; Maria Gabriella Scordo
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

3.  The effects of desmethylimipramine on the pharmacological actions of alpha methyldopa in man.

Authors:  J L Reid; A J Porsius; C Zamboulis; G Polak; C A Hamilton; C R Dean
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

4.  Absence of an effect of mianserin on the actions of clonidine or methyldopa in hypertensive patients.

Authors:  H L Elliott; K McLean; D J Sumner; J L Reid
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Assessment of the interaction between mianserin and centrally-acting antihypertensive drugs.

Authors:  H L Elliott; B Whiting; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

6.  Pharmacodynamic studies on mianserin and its interaction with clonidine.

Authors:  H L Elliott; K McLean; D J Sumner; J L Reid
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.